UniProt/SwissProt ID: | TNAP3_HUMAN |
Description: | tumor necrosis factor, alpha-induced protein 3 [Source:HGNC Symbol;Acc:11896] |
Location: | chr6 q23.3 |
Node attribute: | deubiquitination(source) |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S578 | SPSPHsCHRAG | PhosphoSitePlus; HPRD | |
Y673 | TMFEGyCQKCF | zf-A20 | PhosphoSitePlus |
T647 | GKVSPtASRFQ | PhosphoSitePlus | |
S381 | SVPQLsLMDVK | PhosphoSitePlus | |
S568 | SKSDPsRLVRS | PhosphoSitePlus; phosphoELM | |
Y306 | KLLKEyLMVIE | HPRD | |
S573 | SRLVRsPSPHS | PhosphoSitePlus; HPRD | |
S575 | LVRSPsPHSCH | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
S645 | ASGKVsPTASR | PhosphoSitePlus; HPRD; phosphoELM | |
Y631 | LCFIEyRENKH | PhosphoSitePlus | |
S459 | TGGPHsAPPTA | PhosphoSitePlus; HPRD; phosphoELM | |
Y778 | AKCNGyCNECF | zf-A20 | PhosphoSitePlus |
T454 | NPEEStGGPHS | PhosphoSitePlus | |
T322 | WDHGTtHLINA | HPRD | |
Y614 | KAGCVyFGTPE | zf-A20 | PhosphoSitePlus |
T321 | GWDHGtTHLIN | HPRD | |
T617 | CVYFGtPENKG | zf-A20 | PhosphoSitePlus |
S466 | PPTAPsPFLFS | PhosphoSitePlus | |
S649 | VSPTAsRFQNT | PhosphoSitePlus; HPRD; SysPTM | |
T179 | MASTDtPMARS | OTU | PhosphoSitePlus |
T625 | NKGFCtLCFIE | zf-A20 | PhosphoSitePlus |
S699 | EQLRSsQRRDV | PhosphoSitePlus | |
Dephosphorylation site |
TNAP3_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000237289 | V93fs*3 | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | Q737K | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | A18P | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | W317* | COSMIC | Lymphoma | 19412163 |
ENSP00000237289 | V571I | COSMIC | Lymphoma | 19412163 |
ENSP00000237289 | P574L | COSMIC | Lymphoma | 21266526 |
ENSP00000237289 | S190* | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | G185* | COSMIC | Lymphoma | 22102703 |
ENSP00000237289 | E661* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | L335* | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | T474N | COSMIC | Lymphoma | 19412163 |
ENSP00000237289 | W356* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | P758R | COSMIC | Lymphoma | 20544211 |
ENSP00000237289 | C103G | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000237289 | N102S | COSMIC | Lymphoma | 19608751 |
ENSP00000237289 | S459* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | D117V | COSMIC | Lymphoma | 21266526 |
ENSP00000237289 | E3* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | A586T | COSMIC | Lymphoma | 21406721 |
ENSP00000237289 | W168* | COSMIC | Lymphoma | 19412163 |
ENSP00000237289 | L302P | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | L421V | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000237289 | Y614C | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000237289 | R183* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | P457fs*20 | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | P431L | COSMIC | Lung Cancer | 20668451 |
ENSP00000237289 | N776S | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000237289 | K20Q | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000237289 | C721fs*71 | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | V377M | COSMIC | Lung Cancer | |
ENSP00000237289 | A753T | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | Q593* | COSMIC | Lymphoma | 19907439 |
ENSP00000237289 | P235T | COSMIC | Lymphoma | 20544211 |
ENSP00000237289 | E452* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | N776S | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000237289 | E781D | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | R271* | COSMIC | Lymphoma | 19412163 |
ENSP00000237289 | P656L | COSMIC | Lung Cancer | |
ENSP00000237289 | E88* | COSMIC | Lymphoma | 21406721 |
ENSP00000237289 | W85* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | N163fs*53 | COSMIC | Lymphoma | 19258598 |
ENSP00000237289 | E751K | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | N772K | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | E332* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | K31* | COSMIC | Lymphoma | 21406721 |
ENSP00000237289 | C103G | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000237289 | Q737* | COSMIC | Lymphoma | 22102703 |
ENSP00000237289 | R364G | COSMIC | Lymphoma | 19412163 |
ENSP00000237289 | Q490* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | M476I | COSMIC | Lymphoma | 21266526 |
ENSP00000237289 | W142* | COSMIC | Lymphoma | 19380639 |
ENSP00000237289 | C54* | COSMIC | Lymphoma | 19412164 |
ENSP00000237289 | E154* | COSMIC | Lymphoma | 19907439 |
Differential expressed protein |
TNAP3_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
TNAP3_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
TNAP3_HUMAN | RIPK1_HUMAN | ubiquitination | NetPath |
TNAP3_HUMAN | RIPK1_HUMAN | deubiquitination | NetPath |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05162 | Measles |
hsa04621 | NOD-like receptor signaling pathway |
hsa05169 | Epstein-Barr virus infection |
hsa04064 | NF-kappa B signaling pathway |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0002237 | response to molecule of bacterial origin | IEA | biological_process |
GO:0043130 | ubiquitin binding | IPI | molecular_function |
GO:0002020 | protease binding | IPI | molecular_function |
GO:0070429 | negative regulation of nucleotide-binding oligomer | IEA | biological_process |
GO:0034136 | negative regulation of toll-like receptor 2 signal | NAS | biological_process |
GO:0008270 | zinc ion binding | IEA | molecular_function |
GO:0032720 | negative regulation of tumor necrosis factor produ | IEA | biological_process |
GO:0032495 | response to muramyl dipeptide | IEA | biological_process |
GO:0019900 | kinase binding | IEA | molecular_function |
GO:0005737 | cytoplasm | IEA | cellular_component |
GO:0070536 | protein K63-linked deubiquitination | IDA | biological_process |
GO:0005813 | centrosome | IDA | cellular_component |
GO:0061043 | regulation of vascular wound healing | NAS | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0016579 | protein deubiquitination | IEA | biological_process |
GO:2000349 | negative regulation of CD40 signaling pathway | IMP | biological_process |
GO:0035872 | nucleotide-binding domain, leucine rich repeat con | TAS | biological_process |
GO:0004843 | ubiquitin-specific protease activity | IDA | molecular_function |
GO:0072573 | tolerance induction to lipopolysaccharide | IMP | biological_process |
GO:0005764 | lysosome | IEA | cellular_component |
GO:0043066 | negative regulation of apoptotic process | NAS | biological_process |
GO:0002677 | negative regulation of chronic inflammatory respon | IEA | biological_process |
GO:0050728 | negative regulation of inflammatory response | IEA | biological_process |
GO:0032715 | negative regulation of interleukin-6 production | IEA | biological_process |
GO:0050691 | regulation of defense response to virus by host | NAS | biological_process |
GO:0004221 | ubiquitin thiolesterase activity | IMP | molecular_function |
GO:0070433 | negative regulation of nucleotide-binding oligomer | IEA | biological_process |
GO:0071222 | cellular response to lipopolysaccharide | IDA | biological_process |
GO:0003677 | DNA binding | IEA | molecular_function |
GO:0045779 | negative regulation of bone resorption | NAS | biological_process |
GO:0045087 | innate immune response | TAS | biological_process |
GO:0006508 | proteolysis | IEA | biological_process |
GO:0050728 | negative regulation of inflammatory response | ISS | biological_process |
GO:0001922 | B-1 B cell homeostasis | IEA | biological_process |
GO:2000347 | positive regulation of hepatocyte proliferation | IEA | biological_process |
GO:0002634 | regulation of germinal center formation | IEA | biological_process |
GO:0004842 | ubiquitin-protein ligase activity | IDA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0043621 | protein self-association | IDA | molecular_function |
GO:0050869 | negative regulation of B cell activation | IEA | biological_process |
GO:0034144 | negative regulation of toll-like receptor 4 signal | NAS | biological_process |
GO:0070423 | nucleotide-binding oligomerization domain containi | TAS | biological_process |
GO:0060548 | negative regulation of cell death | IEA | biological_process |
GO:0048662 | negative regulation of smooth muscle cell prolifer | IDA | biological_process |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0032703 | negative regulation of interleukin-2 production | IMP | biological_process |
GO:0090291 | negative regulation of osteoclast proliferation | NAS | biological_process |
GO:2000352 | negative regulation of endothelial cell apoptotic | IDA | biological_process |
GO:0045732 | positive regulation of protein catabolic process | IDA | biological_process |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB c | IDA | biological_process |
GO:0034148 | negative regulation of toll-like receptor 5 signal | IEA | biological_process |
GO:0043027 | cysteine-type endopeptidase inhibitor activity inv | NAS | molecular_function |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0032088 | negative regulation of NF-kappaB transcription fac | IDA | biological_process |
GO:0034140 | negative regulation of toll-like receptor 3 signal | IDA | biological_process |
GO:0070936 | protein K48-linked ubiquitination | IDA | biological_process |
GO:0043154 | negative regulation of cysteine-type endopeptidase | IDA | biological_process |
GO:0032691 | negative regulation of interleukin-1 beta producti | IEA | biological_process |
GO:0045736 | negative regulation of cyclin-dependent protein ki | IEA | biological_process |
GO:0032480 | negative regulation of type I interferon productio | TAS | biological_process |
GO:0031397 | negative regulation of protein ubiquitination | IDA | biological_process |
GO:0051259 | protein oligomerization | NAS | biological_process |
GO:0006954 | inflammatory response | IEA | biological_process |